Varex Imaging CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Varex Imaging's Q3 filing reveals revenue growth driven by the Industrial segment and a significant boost from tariff refunds, though Medical segment sales declined.
NASDAQ
Varex Imaging Corporation's Q2 filing shows a 1.5% revenue increase to $216.0 million, but a net loss of $8.1 million compared to a profit in the prior year.
NASDAQ
Varex Imaging Corporation reported a net income of $2.3 million for Q1 fiscal year 2026, driven by strong Industrial segment revenue growth and improved operating efficiency, despite challenges in the Medical segment.
NASDAQ
Varex Imaging Corporation reported a significant net loss for the third fiscal quarter of 2025, primarily driven by a $93.9 million goodwill impairment charge in its Medical segment.
NASDAQ
Varex Imaging Corporation reports increased revenue and profitability for the second quarter of fiscal year 2025, while navigating potential impacts from tariffs and trade investigations.
NASDAQ
Varex Imaging Corporation reports a revenue increase for the quarter ended January 3, 2025, while addressing ongoing economic and industry challenges.
NASDAQ
Varex Imaging Corporation reported a decrease in revenue for the third quarter of 2024, primarily due to lower sales in its Medical segment, while the Industrial segment showed modest growth.
NASDAQ
Varex Imaging Corporation's second quarter results show a decrease in revenue and profit compared to the previous year, impacted by economic uncertainty and supply chain challenges.
NASDAQ
Varex Imaging Corporation reported a net loss for the first quarter of fiscal year 2024, with revenue declining year-over-year, while facing ongoing economic and supply chain challenges.